Target intelligence / Profile preview

Solute carrier family 25 member 46 (SLC25A46)

Target
SLC25A46
Molecular classification
Transporter (member of the SLC25 solute carrier family), Mitochondrial outer membrane protein
01

Overview

Solute carrier family 25 member 46 (SLC25A46) is a multi-pass transmembrane protein of the mitochondrial outer membrane and an orphan member of the SLC25 mitochondrial transporter family[2][3]. It is crucial for the regulation of mitochondrial fission and fusion, maintenance of cristae structure, and interorganellar lipid transfer, notably from the endoplasmic reticulum[2][1]. SLC25A46 interacts with core components of the fusion and MICOS machinery—including MFN2, OPA1, and mitofilin (IMMT)—to modulate mitochondrial architecture[3][4][1]. Pathogenic loss-of-function variants cause fragmentation or hyperfusion of mitochondria, shortened cristae, impaired respiration, premature cellular senescence, and significant neurological disease such as HMSN6B, Leigh syndrome, and Charcot-Marie-Tooth disease[2][4][1]. SLC25A46 does not have direct clinically approved drug modulators or antagonists in current use or research based on available information.

Other names
Mitochondrial outer membrane protein SLC25A46TB1HMSN6BPCH1ESolute carrier family 25 member 46
02

Biological functions

Mitochondrial fission and fusion regulationMaintenance of mitochondrial cristae architectureInterorganellar lipid transfer/homeostasisInvolvement in cell fate decisions (senescence, proliferation)Regulator of MICOS complex assembly and mitochondrial dynamics
03

Disease associations

Neurodegenerative disease (Leigh syndrome, optic atrophy spectrum, Charcot-Marie-Tooth disease)Hereditary motor and sensory neuropathy type 6B (HMSN6B)Progressive visual lossMitochondrial-associated neuropathiesPremature cellular senescence
04

Safety considerations

Deficiency leads to severe neurodegenerative and developmental phenotypes, including early-onset neuropathy, optic atrophy, premature cellular senescence, and impaired cellular respirationLoss of function alters mitochondrial lipid composition and destabilizes MICOS, impacting cell migration and energy metabolism
05

Biomarkers

Mutations or deficiency of SLC25A46 serve as genetic biomarkers for HMSN6B, Leigh syndrome, and some optic atrophy spectrum disorders

Beyond the preview

Go deeper on Solute carrier family 25 member 46 (SLC25A46).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 46 (SLC25A46).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call